Genomic Space of MGMT in Human Glioma Revisited: Novel Motifs, Regulatory RNAs, NRF1, 2, and CTCF Involvement in Gene Expression.

Abstract

BACKGROUND:

The molecular regulation of increased MGMT expression in human brain tumors, the associated regulatory elements, and linkages of these to its epigenetic silencing are not understood. Because the heightened expression or non-expression of MGMT plays a pivotal role in glioma therapeutics, we applied bioinformatics and experimental tools to identify the regulatory elements in the MGMT and neighboring EBF3 gene loci.

RESULTS:

Extensive genome database analyses showed that the MGMT genomic space was rich in and harbored many undescribed RNA regulatory sequences and recognition motifs. We extended the MGMT's exon-1 promoter to 2019 bp to include five overlapping alternate promoters. Consensus sequences in the revised promoter for (a) the transcriptional factors CTCF, NRF1/NRF2, GAF, (b) the genetic switch MYC/MAX/MAD, and (c) two well-defined p53 response elements in MGMT intron-1, were identified. A putative protein-coding or non-coding RNA sequence was located in the extended 3' UTR of the MGMT transcript. Eleven non-coding RNA loci coding for miRNAs, antisense RNA, and lncRNAs were identified in the MGMT-EBF3 region and six of these showed validated potential for curtailing the expression of both MGMT and EBF3 genes. ChIP analysis verified the binding site in MGMT promoter for CTCF which regulates the genomic methylation and chromatin looping. CTCF depletion by a pool of specific siRNA and shRNAs led to a significant attenuation of MGMT expression in human GBM cell lines. Computational analysis of the ChIP sequence data in ENCODE showed the presence of NRF1 in the MGMT promoter and this occurred only in MGMT-proficient cell lines. Further, an enforced NRF2 expression markedly augmented the MGMT mRNA and protein levels in glioma cells.

CONCLUSIONS:

We provide the first evidence for several new regulatory components in the MGMT gene locus which predict complex transcriptional and posttranscriptional controls with potential for new therapeutic avenues.

• Authors: Mohammed A Ibrahim Al-Obaide, Viswanath Arutla, Manny D Bacolod, Wei Wang, Ruiwen Zhang, Kalkunte S Srivenugopal
• Journal: International journal of molecular sciences (Int J Mol Sci) Vol. 22 Issue 5 (Mar 02 2021) ISSN: 1422-0067 [Electronic] Switzerland
• PMID: 33801310 (Publication Type: Journal Article)

Chemical References

• Biomarkers, Tumor
• CCCTC-Binding Factor
• CTCF protein, human
• NF-E2-Related Factor 2
• NFE2L2 protein, human
• NRF1 protein, human
• Nuclear Respiratory Factor 1
• RNA, Small Interfering
• RNA, Untranslated
• Tumor Suppressor Proteins
• DNA Modification Methylases
• MGMT protein, human
• DNA Repair Enzymes

Topics

• Biomarkers, Tumor (genetics, metabolism)
• Brain Neoplasms (genetics, metabolism, pathology)
• CCCTC-Binding Factor (genetics, metabolism)
• DNA Methylation
• DNA Modification Methylases (genetics, metabolism)
• DNA Repair Enzymes (genetics, metabolism)
• Epigenesis, Genetic
• Gene Expression Regulation, Neoplastic
• Genomics
• Glioma (genetics, metabolism, pathology)
• Humans
• NF-E2-Related Factor 2 (genetics, metabolism)
• Nuclear Respiratory Factor 1 (genetics, metabolism)
• Promoter Regions, Genetic
• RNA, Small Interfering (genetics)
• RNA, Untranslated (genetics)
• Regulatory Sequences, Nucleic Acid
• Tumor Suppressor Proteins (genetics, metabolism)